The medical device industry is struggling, with a forecast of single-digit overall growth for 2014. To cope with that, devicemakers are outsourcing more and more of their critical operations and materials, trying to wring out costs and improve their profitability.The unintended consequence? A much, much greater risk of supplier control violations.
This is the year that drug- and devicemakers will need to begin reporting – for the whole world to see — the types of financial arrangements they have with physicians and teaching hospitals. Planning for disclosure is one thing. Actually carrying it out will be another altogether. Are you ready for the host of challenges, headaches and questions that are about to land on your desk? If not, read on …
In this 90-minute audio CD/transcript, Cyrus
Mehta, Ph.D., cofounder and president of Cytel Inc., will present three
in-depth case studies where an adaptive design was used to modify the
initial assumptions and improve the design, using interim data from the trial